Infectious Disease
Powerful & Precise Nanomedical Solutions
Overview
Transforming Infectious Disease Treatment with SNAP
At POP Biotechnologies, we leverage our POP BIO SNAP technology to tackle infectious diseases head-on. Our innovative approach enhances the development of targeted therapies and vaccines.
Targeted Solutions
SNAP technology enables precise targeting of pathogens for effective treatment and prevention.
Rapid Development
Accelerating vaccine development to combat emerging infectious diseases swiftly and efficiently.
Hexavalent Seasonal Influenza Vaccine: SNAPflu
SNAP Liposome
We can attach proteins derived from separate influenza viruses. Creating a powerful new influenza vaccine with broader coverage and lasting immunity.
Influenza Viruses
Proteins are derived from
separate flu viruses
Comparison of SNAPflu vs current vaccines
BALB/c mice were immunized on Days 0 and 21 with indicated vaccines (0.3 µg per antigen for SNAP-Flu or FLUAD® and 1.8 µg for Flublok®). Serum and spleen were collected on Day 42 or alternatively mice were challenged with heterologous viral strains on that day.
A
D
Murine challenge with 10X LD50 of indicated virus strain.
B
HAI titers against challenge strains used
C
ELIspot results reflecting antigen re-stimulation with indicated antigen.
